Title: Due of Antibiotics in Pediatric LRTI Patients

Authors: Anusha Yerraboina*, Varun Tripuraneni, Hemavathi Neelamshetti

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i3.37

Abstract

DUE is an ongoing, systematic process designed to maintain the appropriate and effective uses of drugs. DUE may be applied to a drug or therapeutic class, or diagnosis. DUE is typically classified into three different categories: prospective, concurrent and retrospective. Drugs prescribed for children are the same as those originally developed for adults. However, growth and development processes in children, in addition to disease profile, might expose them to different adverse effects. This study aimed at understanding drug utilization patterns in pediatric patients at a tertiary care hospital in Hyderabad. A prospective study was carried out on 106 pediatric patients diagnosed to have LRTI. It was found that the third generation Cephalosporins was the most commonly prescribed, ceftriaxone being the highest among all. This study focused on the analysis of prescriptions in the management of LRTI in pediatric patients.

Keywords: Cephalosporins, DUE, LRTI, Pediatric patients.

References

1.      Rajesh Kumar Suman, Ipseeta Ray Mohanty, Y A Deshmukh. The concepts of Drug Utilization Study, Vol : 3, Issue : 10,352-363

2.      Sathvik BS., Drug utilization review/ evaluation, in Parthasarathi G, Nyfon-Hansen K, Nahata MC (eds), A textbook of clinical pharmacy practice. 1st ed.,orient Longman, India, 362-375, 2004

3.      Sukesh Krishna Chaitanya Loka et al. Evaluation of Beta blockers use at a tertiary care hospital. Indo American Journal of Pharm Research2015:5(07).

4.      Shalini S, Ravichandran V, Mohanty BK, Dhanaraj SK, Saraswati R. Drug utilization studies – an overview. Intern J Pharma Sci Nanotech 2010; 3(1): 803-10.

5.      Lemecha Diriba, Fikru Worku, Tsinuel Girma. Evaluation of prophylactic use of cotromoxazole for people living with HIV/AIDS in Jimma University specialized hospital, Southwest Ethiopia. Ethiop J Health Sciences 2008; 18(3):59-64.

6.      You ML, Chun Y, Yung TK, Man YH, Hsiang YC. Outcomes of pharmacy interventions on pediatric medication prescribing patterns in Taiwan. Int J Clin Exp Med. 2010; 2:173–80.

7.      Serradell J, Bjornson DC & Hartzema AG. Drug Utilization Study Methodologies: National and International Perspectives. Drug Intelligence and Clinical Pharmacy. 1987; 21(12, December):994-1001.

8.      Navarro, Robert. Chapter 8: Drug Utilization Review Strategies. In Managed Care Pharmacy Practice, published 2008, pp. 215 –229.

Corresponding Author

Anusha Yerraboina

1-1-241/143, Plot 5, Bhavani Nagar Colony

Kapra, ECIL, Secunderabad- 500062

Email: This email address is being protected from spambots. You need JavaScript enabled to view it., Phone Num: 8801654126